Gallbladder adenocarcinoma
Prepared with OnCo (onco.cc/prep/gallbladder-adenocarcinoma/). Orientation, not medical advice; your team knows your case.
My details
What I know, what is unclear, changes to discuss
Saved in this browserMy questions
11 on the sheet- 1.What is my exact diagnosis, stage, and grade, and which tests established them?
- 2.Which biomarkers have been tested on my tumour (for example Grade 1 to 3, T category and T2a or T2b side, Node number, Cystic duct margin, HER2, mismatch repair, BRAF V600E and NTRK on the molecular page), and what were the results?
- 3.Which subtype is my cancer, and does that change the recommended treatment?
- 4.Is germline (inherited) genetic testing recommended for me or my family?
- 5.For my situation (resectable disease), which of the standard options do you recommend and why?
- 6.Am I a candidate for Capecitabine, and what side effects should I expect?
- 7.How do the results of BILCAP apply to someone like me?
- 8.For my situation (advanced disease), which of the standard options do you recommend and why?
- 9.Am I a candidate for Gemcitabine + cisplatin, Durvalumab, Pembrolizumab or related drugs, and what side effects should I expect?
- 10.Would a second opinion at a high-volume centre change anything, and can you help arrange it?
- 11.What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?
The words I may hear
- T2a versus T2b gallbladder cancer (peritoneal side versus hepatic side): Two labels for a gallbladder cancer that has grown through the muscle layer but is still inside the gallbladder.
- Segment IVb and V liver resection (versus wedge resection): Two ways of removing the piece of liver the gallbladder sits on during a gallbladder cancer operation: a wedge of about two centimetres around the gallbladder bed, or the whole of the two anatomical liver segments (IVb and V) that touch it.
- Cystic duct margin: The cut end of the short duct that joined the gallbladder to the main bile duct, examined by the pathologist after a gallbladder is removed.
- Simple cholecystectomy: The standard operation to remove the gallbladder, almost always by keyhole surgery for gallstones.
- Radical (extended) cholecystectomy: The cancer operation for gallbladder cancer: the gallbladder (if still present) is removed together with a rim of the liver it sits against and the lymph nodes along the bile duct and liver blood vessels.
- Grade: How abnormal the cancer cells look under the microscope, from grade 1 (close to normal, slow) to grade 3 or 4 (wildly abnormal, fast).
Tests and results to bring
Biomarker results to ask for: Grade 1 to 3, T category and T2a or T2b side, Node number (N1 one to three, N2 four or more), Cystic duct margin, HER2, mismatch repair, BRAF V600E and NTRK on the molecular page.
Bring copies of scan reports, pathology and blood results, and a list of every medicine and supplement.
The treatments I may be offered
- Resectable disease: Simple cholecystectomy for Tis and T1a; radical cholecystectomy with liver bed and portal lymphadenectomy from T1b; adjuvant capecitabine (BILCAP). (Simple cholecystectomy, Radical (extended) cholecystectomy, Capecitabine, BILCAP)
- Advanced disease: Gemcitabine and cisplatin with durvalumab or pembrolizumab; zanidatamab for HER2-positive disease after chemotherapy. (Gemcitabine + cisplatin, Durvalumab, Pembrolizumab, Zanidatamab)
From the standard of care recorded for this cancer; which apply depends on your stage and biomarkers. Ask which the team recommends and why.